Loss of the tumor suppressor BAP1 causes myeloid transformation

Anwesha Dey, Dhaya Seshasayee, Rajkumar Noubade, Dorothy M. French, Jinfeng Liu, Mira S. Chaurushiya, Donald S. Kirkpatrick, Victoria C. Pham, Jennie R. Lill, Corey E. Bakalarski, Jiansheng Wu, Lilian Phu, Paula Katavolos, Lindsay M. LaFave, Omar Abdel-Wahab, Zora Modrusan, Somasekar Seshagiri, Ken Dong, Zhonghua Lin, Mercedesz BalazsRowena Suriben, Kim Newton, Sarah Hymowitz, Guillermo Garcia-Manero, Flavius Martin, Ross L. Levine, Vishva M. Dixit

Research output: Contribution to journalArticlepeer-review

317 Scopus citations


De-ubiquitinating enzyme BAP1 is mutated in a hereditary cancer syndrome with increased risk of mesothelioma and uveal melanoma. Somatic BAP1 mutations occur in various malignancies. We show that mouse Bap1 gene deletion is lethal during embryogenesis, but systemic or hematopoietic-restricted deletion in adults recapitulates features of human myelodysplastic syndrome (MDS). Knockin mice expressing BAP1 with a 3xFlag tag revealed that BAP1 interacts with host cell factor-1 (HCF-1), O-linked N-acetylglucosamine transferase (OGT), and the polycomb group proteins ASXL1 and ASXL2 in vivo. OGT and HCF-1 levels were decreased by Bap1 deletion, indicating a critical role for BAP1 in stabilizing these epigenetic regulators. Human ASXL1 is mutated frequently in chronic myelomonocytic leukemia (CMML) so an ASXL/BAP1 complex may suppress CMML. A BAP1 catalytic mutation found in a MDS patient implies that BAP1 loss of function has similar consequences in mice and humans.

Original languageEnglish (US)
Pages (from-to)1541-1546
Number of pages6
Issue number6101
StatePublished - Sep 21 2012
Externally publishedYes

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Loss of the tumor suppressor BAP1 causes myeloid transformation'. Together they form a unique fingerprint.

Cite this